3 studies found for:    FANCONI ANEMIA, COMPLEMENTATION GROUP B
Show Display Options
Rank Status Study
1 Recruiting A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers
Conditions: Respiratory Syncytial Viruses;   Respiratory Tract Infections
Interventions: Biological: Ad26.RSV.FA2;   Biological: Ad35.RSV.FA2;   Drug: Placebo
2 Completed A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants
Condition: Healthy Participants
Interventions: Biological: Ad35.RSV.FA2;   Biological: Ad26.RSV.FA2;   Drug: Placebo
3 Completed
Has Results
A Study of TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment
Condition: Hepatitis C
Interventions: Drug: TMC435;   Drug: Ribavirin (R);   Drug: PegIFNα-2a (P);   Drug: Placebo

Indicates status has not been verified in more than two years